HCSG
Healthcare Services Group Inc
$23.39
▲ 6.6%Updated Aug 19, 11:10 AM ET
HCSG at a glance — five pillars scored 0–100 from real filed financials.
Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Market Cap
$0.00
P/E
—
Forward P/E (est.)
—
ROE
—
Revenue Growth
—
EPS Growth
—
Profit Margin
—
FCF Yield
—
Debt / Equity
—
ROIC
—
Interest Coverage
—
Current Ratio
3.02x
Dividend Yield
—
Implied Growth (rev. DCF)
—
Rating Score
0/100
Healthcare Services Group Inc (HCSG) is a small-cap company in the Commercial Services & Supplies industry, part of the Industrials sector of the S&P 500.
In its latest reported year it generated about $1.84B in revenue and $59.06M in net profit.
Our model rates HCSG Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
2.8%
Revenue moved from $1.86B in 2017 to $1.84B in 2025, a -0.2% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.
Gross Margin
—
Operating Margin
—
Net Margin
3.2%
ROE
—
Total Debt
—
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Leverage: debt-to-equity is n/a, with a current ratio of 3.0x. Detailed balance-sheet leverage is limited for this name.
Operating CF
$144.97M
Free Cash Flow
$139.15M
FCF Margin
7.6%
In the latest year Healthcare Services Group Inc produced about $144.97M of operating cash flow and $139.15M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Per share (latest FY)
$0.86
Total paid (latest FY)
$63.37M
History on record
6 years
dividend uses 46% of free cash flow
107% of net income paid out
total dividends increased 5 years in a row
no cuts in the last 6 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
—
P/S
—
P/B
—
EV / EBITDA
—
HCSG trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$34.81
Current price
$23.39
Starting FCF (latest 10-K)
$139.15M
Growth, years 1–5
4.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where HCSG sits versus its Industrials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 144 Industrials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How HCSG stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.
In the Industrials sector (273 S&P 500 companies), HCSG ranks #192 of 273 by our overall rating.
P/E vs sector
—
median 31.4x
ROE vs sector
—
median 18.1%
Growth vs sector
—
median 6.0%
Sector rank
#192
of 273 by rating
Peers are the closest Industrials companies by sub-industry and size. Sector median is across all 273 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $23.39 today · expected CAGR -10% – 0%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $1.98B | $2.14B | $2.31B | $2.50B | $2.70B |
| Net income | $59.52M | $64.29M | $69.43M | $74.98M | $80.98M |
| EPS | $0.87 | $0.94 | $1.01 | $1.09 | $1.18 |
| Share price (low) | $10.41 | $11.24 | $12.14 | $13.11 | $14.16 |
| Share price (high) | $17.35 | $18.73 | $20.23 | $21.85 | $23.60 |
| CAGR (low–high) | -56% / -26% | -31% / -11% | -20% / -5% | -13% / -2% | -10% / 0% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for HCSG:
- As an established S&P 500 member in Industrials, it brings scale and a long operating history.
The case against HCSG:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Healthcare Services Group Inc is a small-cap industrials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 12 Wall Street analysts covering HCSG recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Latest SEC Filings
HCSG's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
HCSG — frequently asked questions
Is HCSG a good stock to buy?
We don't give buy or sell advice. Review Healthcare Services Group Inc's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.
Where does HCSG's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Healthcare Services Group Inc's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for HCSG calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this HCSG analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell HCSG. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.